What question did this study set out to answer?

To review the global public health impact of age-related macular degeneration and examine emerging pathogenetic mechanisms, with a focus on complement pathway genetics and targeted therapies.

January 1, 2006Annals of MedicineOpen Access

Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts

View Full Paper

Ask AI

Bookmark

Authors

KGKaren M. GehrsUniversity of Iowa Health Care DADon H. AndersonUniversity of California, Santa Barbara LJLincoln V. JohnsonUniversity of California, Santa Barbara

Discussion

Member takes

Implication

Review uncovers complement pathway dysregulation in elderly individuals with macular degeneration, highlighting complement factor H as a target for novel therapies.

Key Points

To review the global public health impact of age-related macular degeneration and examine emerging pathogenetic mechanisms, with a focus on complement pathway genetics and targeted therapies.
Synthesized World Health Organization epidemiological survey data on global vision loss and blindness.
Evaluated current standard therapies for dry and wet forms of age-related macular degeneration.
Reviewed genetic association and molecular pathway findings related to innate immune regulation and complement factor H.
Age-related macular degeneration impairs or blinds approximately 14 million people globally, with antioxidants delaying progression in only 20% to 25% of dry-form eyes.
Uncontrolled regulation of the alternative complement pathway within the innate immune system serves as a central driver of macular pathogenesis.
The complement Factor H gene represents the first confirmed genetic risk factor identified across independent studies for developing the disease.

Cite This Study

Gehrs et al. (2006) studied this question.

synapsesocial.com/papers/69ca95f898eb56b06163991d https://doi.org/10.1080/07853890600946724

View Full Paper

Ask AI

Bookmark

Implication

Review uncovers complement pathway dysregulation in elderly individuals with macular degeneration, highlighting complement factor H as a target for novel therapies.

Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts

Discussion

Member takes

Implication

Key Points

Cite This Study

Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider